Protalix investing
Webb31 mars 2024 · Of the 23 institutional investors that purchased Protalix BioTherapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Psagot Investment House Ltd. ($2.63M), Morgan Stanley ($1.86M), DAFNA Capital Management LLC ($1.20M), Meitav Dash Investments Ltd. … Webb6 jan. 2024 · By Investing.com - Feb 27, 2024 Protalix BioTherapeutics (PLX) reported Q4 EPS of ($0.22), $0.07 worse than the analyst estimate of ($0.15). Revenue for the quarter …
Protalix investing
Did you know?
Webb10 feb. 2024 · Investing Groups Leader Follow Summary Shares of plant-derived enzyme therapy concern Protalix BioTherapeutics, Inc. have rallied after its Fabry disease asset PLX-102 received a PDUFA date of... Webb28 mars 2024 · The average price point forecasted by analysts for Protalix BioTherapeutics Inc. (PLX) is $11.00, The public float for PLX is 48.36M, and currently, short sellers hold a 10.65% ratio of that floaft. The average trading volume of PLX on March 28, 2024 was 993.42K shares. PLX) stock’s latest price update
WebbProtalix Biotherapeutics Inc Interactive Stock Chart (PLX) - Investing.com Free Webinar - Trade timing secrets for success Thursday, February 23, 2024 01:00PM PST Enroll … Webb13 apr. 2024 · With the market capitalization of Protalix BioTherapeutics Inc. currently standing at about $135.59 million, investors are eagerly awaiting this quarter’s results, scheduled for May 15, 2024 – May 19, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report.
WebbDenna sida presenterar resultaträkningen (vinst- och förlusträkning) för Protalix Biotherapeutics Inc. Hitta bolagets finansiella resultat, intäkter och mycket mer. WebbAlla relevanta kommentarer och diskussioner sammanställda om PLX Aktien.
WebbProtalix has partnered with Pfizer for worldwide development and commercialization of ELELYSO, excluding Israel, where Protalix has retained full rights. ... Protalix BioTherapeutics has 11 investors including Cybele Holdings and …
WebbKassaflödesanalys för Protalix Biotherapeutics Inc, bolagets kassalikviditet, som bryts ner till löpande-, investerings- och finansieringsverksamhet. hbiw reactionWebbProtalix is dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with our ProCellEx ® plant cell-based expression system … gold and white display shelvesWebb21 mars 2024 · This table contains core financial ratios such as Price-to-Earnings , Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on Protalix Biotherapeutics Inc's latest ... hbi urban dictionaryWebbInvesting.com användarnas resultattavla för Protalix Biotherapeutics Inc aktien. hbits new yorkWebb27 feb. 2024 · Get the latest Protalix earnings report, revenues and EPS as well as upcoming PLX earnings dates. hbi wholesaleWebb11 okt. 2024 · Protalix was the first company to gain U.S. Food and Drug Administration (FDA) approval of a protein produced through plant cell-based in suspension expression system. Protalix's unique expression system represents a new method for developing recombinant proteins in an industrial-scale manner. hbjc375f3a-2930-bWebbDenna sida innehåller balansräkningen för Protalix Biotherapeutics Inc, som sammanfattar bolagets finansiella ställning, inklusive tillgångar, skulder och mycket mer. Heta nyheter … hb ives co